Trying to bring Sputnik M vaccine for adolescents to India: Dr Reddy's

: Dr Reddy's Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russia's Sputnik M, a COVID-19 vaccine for the 12 to18-year-old category, to India.

Addressing a press conference after announcing the company's Q3 results, a senior executive of the drug maker said Phase 3 clinical trial data of Russia's single dose COVID-19 vaccine Sputnik Light has been submitted to the regulator and is awaiting approval.

Deepak Sapra CEO API and Services Dr. Reddy's, also said the company is fully geared to make Molnupiravir, a COVID-19 drug both API and Formulations, at its facilities, even as it approached World Health organization for the prequalification of the drug.